Used in pharmaceutical research as a potent and selective inhibitor of Janus kinase 2 (JAK2), particularly in the development of treatments for myeloproliferative disorders. Shows promise in targeting abnormal signaling pathways involved in blood-related cancers and inflammatory diseases. Its structure enables high binding affinity to the JAK2 enzyme, helping suppress uncontrolled cell proliferation. Also serves as a lead compound for optimizing new kinase inhibitors with improved efficacy and reduced side effects.